Dr George Fareed Interview - Part 2

In the second part of our interview with the esteemed Dr George Fareed, MD, we cover a range of critical questions regarding the treatment of COVID-19. Dr Fareed’s ability to get early treatment to his patients, given the context of restrictions by many medical and pharmacy boards, and by several major pharmacy chains - his results with the early treatment of some 300 patients early treatment as a means to avoid long-term effects, to avoid for the patient to become a long-hauler - how Dr Fareed treated residents of a nursing home, following a major, rapid, outbreak; what was the result of the intervention; how did the families support the treatment - the recommendations of Dr Fareed for those managing nursing homes, in terms of prophylaxis and early treatment how staff was protected and treated early in case of an infection - the emergence of Ivermectin-based treatments, as an alternative option to Hydroxychloroquine-based therapies, for the early treatment of COVID-19 - what kind of prophylaxis does Dr Fareed, who has been extensively exposed to the virus, take for himself - the tragedy of early treatment not to being recognized, or being out rightly opposed, by the authorities in the US